NRX Pharmaceuticals (NRXP) vs Retension Pharmaceuticals (RTSN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 18, 2026.
Summary
Retension Pharmaceuticals is the larger company by market cap ($117.2 million vs $112.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NRXP | RTSN |
|---|---|---|
| Share price | $2.60 | $14.07 |
| Market cap | $112.57M | $117.23M |
| 1-day change | -4.06% | +15.23% |
| YTD return | -4.06% | — |
| 1-year return | -18.24% | — |
| 5-year return | -97.37% | — |
| EPS (TTM) | $-0.58 | $-2.61 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $1.23M | — |
| Net income (latest FY) | $-28.62M | — |
| Gross margin | 58.78% | — |
| Operating margin | -1324.41% | — |
| Net margin | -2336.49% | — |
| 52-week high | $5.06 | $14.97 |
| 52-week low | $1.62 | $9.66 |
| Distance from 52-week high | -48.57% | -6.02% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +1380.77% | — |
| Average volume | 860.32K | 252.97K |
| Shares outstanding | 43.30M | 8.33M |
| Employees | 29 | 12 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About NRX Pharmaceuticals
NRXP stock →NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments.
Health Care · Biotechnology: Pharmaceutical Preparations · 29 employees
About Retension Pharmaceuticals
RTSN stock →Retension Pharmaceuticals, Inc. operates as a clinical -stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 12 employees
NRXP vs RTSN FAQ
Which is bigger, NRX Pharmaceuticals or Retension Pharmaceuticals?
Retension Pharmaceuticals (RTSN) is larger, with a market capitalization of $117.23M compared with $112.57M for NRX Pharmaceuticals (NRXP).
Are NRX Pharmaceuticals and Retension Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.